4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063373
President and CEO gave up 863 shares (to pay taxes)
- President and CEO acquired 3,033 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal President and CEO | 2018-12-15 | Option exercise | +3,033 | 908,895 | D | ||
| Walker Neal President and CEO | 2018-12-15 | Shares withheld for taxes | −863 | $7.31 | $6,309 | 908,032 | D |
| Derivatives | |||||||
| Walker Neal President and CEO | 2018-12-15 | Option exercise · Restricted Stock Units | −3,033 | 6,067 | D | ||
Loading xslF345X03/doc4.xml…